HEADER ANTIBIOTIC 06-JAN-06 2CBO TITLE CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 3TES24 MUTANT BOUND TO TITLE 2 TESTOSTERONE HEMISUCCINATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEOCARZINOSTATIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NCS, MITOMALCIN, MMC; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CARZINOSTATICUS; SOURCE 3 ORGANISM_TAXID: 1897; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BLR(DE3)PLYSS KEYWDS ANTIBIOTIC, PHAGE-DISPLAY, HAPTEN BINDING, NEOCARZINOSTATIN, KEYWDS 2 ANTIMICROBIAL, DNA-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK,F.PECORARI,M.DESMADRIL, AUTHOR 2 H.VAN TILBEURGH,P.MINARD REVDAT 4 13-DEC-23 2CBO 1 REMARK REVDAT 3 24-FEB-09 2CBO 1 VERSN REVDAT 2 26-APR-06 2CBO 1 JRNL REVDAT 1 22-MAR-06 2CBO 0 JRNL AUTH A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK,F.PECORARI, JRNL AUTH 2 M.DESMADRIL,H.VAN TILBEURGH,P.MINARD JRNL TITL STRUCTURES OF IN VITRO EVOLVED BINDING SITES ON JRNL TITL 2 NEOCARZINOSTATIN SCAFFOLD REVEAL UNANTICIPATED EVOLUTIONARY JRNL TITL 3 PATHWAYS. JRNL REF J.MOL.BIOL. V. 358 455 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16529771 JRNL DOI 10.1016/J.JMB.2006.02.002 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.HEYD,F.PECORARI,B.COLLINET,E.ADJADJ,M.DESMADRIL,P.MINARD REMARK 1 TITL IN VITRO EVOLUTION OF THE BINDING SPECIFICITY OF REMARK 1 TITL 2 NEOCARZINOSTATIN, AN ENEDIYNE-BINDING CHROMOPROTEIN. REMARK 1 REF BIOCHEMISTRY V. 42 5674 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12741824 REMARK 1 DOI 10.1021/BI0273664 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 187070.780 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.8 REMARK 3 NUMBER OF REFLECTIONS : 10099 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 533 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1404 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE : 0.3690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 83 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.041 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 818 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.60000 REMARK 3 B22 (A**2) : 1.60000 REMARK 3 B33 (A**2) : -3.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.340 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.240 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.810 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.740 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.360 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 57.29 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : THS.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : THS.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CBO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1290027094. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10933 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 1.970 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1NCO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6-1.7M (NH4)2SO4, 0.1 M SODIUM REMARK 280 CITRATE PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.35400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 13.67700 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.03100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 HAS ANTIBIOTIC ACTIVITY FOR GRAM-POSITIVE BACTERIA REMARK 400 AND ANTITUMOR ACTIVITY FOR CERTAIN MOUSE TUMORS REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLY 69 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 71 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TRP 73 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 79 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 81 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 86 TO ASN REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2021 DISTANCE = 5.86 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 117 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 A 120 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 A 121 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J5H RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF APO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 1J5I RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A NOVEL CHROMOPROTEIN DERIVED FROMAPO- REMARK 900 NEOCARZINOSTATIN AND A SYNTHETIC CHROMOPHORE REMARK 900 RELATED ID: 1NCO RELATED DB: PDB REMARK 900 HOLO-NEOCARZINOSTATIN (CONTAINING CHROMOPHORE) COMPLEX WITH APO- REMARK 900 CARZINOSTATIN (CONTAINING MPD) REMARK 900 RELATED ID: 1NOA RELATED DB: PDB REMARK 900 NEOCARZINOSTATIN REMARK 900 RELATED ID: 1O5P RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HOLO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 2CBM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE APO-FORM OF A NEOCARZINOSTATIN MUTANT REMARK 900 EVOLVED TO BIND TESTOSTERONE. REMARK 900 RELATED ID: 2CBQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 1TES15 MUTANT BOUND TO REMARK 900 TESTOSTERONE HEMISUCCINATE. REMARK 900 RELATED ID: 2CBT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 4TES1 MUTANT BOUND REMARK 900 TESTOSTERONE HEMISUCCINATE. DBREF 2CBO A 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBO A 114 115 PDB 2CBO 2CBO 114 115 SEQADV 2CBO TRP A 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBO ALA A 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBO TRP A 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBO ARG A 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBO TRP A 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBO TYR A 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBO ASN A 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQRES 1 A 115 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 A 115 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 A 115 GLN ALA GLY THR ALA TYR TRP VAL ALA GLN TRP ALA ARG SEQRES 4 A 115 VAL ASP THR GLY VAL TRP ALA TYR ASN PRO ALA ASP ASN SEQRES 5 A 115 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 A 115 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 A 115 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 A 115 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 A 115 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS HIS HET SO4 A 117 5 HET TH2 A 120 28 HET TH2 A 121 28 HETNAM SO4 SULFATE ION HETNAM TH2 TESTOSTERONE HEMISUCCINATE HETSYN TH2 4-OXO-4-{[(8ALPHA,9BETA,10ALPHA,13ALPHA,14BETA, HETSYN 2 TH2 17ALPHA)-3-OXOANDROST-4-EN-17-YL]OXY}BUTANOIC ACID FORMUL 2 SO4 O4 S 2- FORMUL 3 TH2 2(C23 H32 O5) FORMUL 5 HOH *116(H2 O) HELIX 1 1 PRO A 49 ASN A 52 5 4 SHEET 1 AA 3 THR A 4 THR A 8 0 SHEET 2 AA 3 VAL A 18 ALA A 24 -1 O LYS A 20 N THR A 8 SHEET 3 AA 3 ALA A 63 THR A 68 -1 O ALA A 63 N GLY A 23 SHEET 1 AB 3 VAL A 44 TYR A 47 0 SHEET 2 AB 3 ALA A 31 ASP A 41 -1 O ALA A 38 N ALA A 46 SHEET 3 AB 3 SER A 53 THR A 56 -1 O SER A 53 N VAL A 34 SHEET 1 AC 4 VAL A 44 TYR A 47 0 SHEET 2 AC 4 ALA A 31 ASP A 41 -1 O ALA A 38 N ALA A 46 SHEET 3 AC 4 ALA A 92 SER A 98 -1 O ALA A 92 N ARG A 39 SHEET 4 AC 4 VAL A 108 ALA A 109 -1 O VAL A 108 N VAL A 95 SHEET 1 AD 2 SER A 72 PHE A 76 0 SHEET 2 AD 2 ARG A 82 ASP A 87 -1 N TRP A 83 O GLY A 75 SSBOND 1 CYS A 88 CYS A 93 1555 1555 2.03 CISPEP 1 THR A 8 PRO A 9 0 -0.29 SITE 1 AC1 6 SER A 14 ASP A 15 ARG A 71 HOH A2113 SITE 2 AC1 6 HOH A2114 HOH A2115 SITE 1 AC2 16 THR A 8 LYS A 20 TRP A 33 ALA A 35 SITE 2 AC2 16 TYR A 47 ASN A 52 PHE A 78 ARG A 82 SITE 3 AC2 16 SER A 98 ALA A 100 ALA A 101 GLY A 102 SITE 4 AC2 16 TH2 A 121 HOH A2012 HOH A2013 HOH A2116 SITE 1 AC3 11 TRP A 37 TRP A 45 PHE A 78 ARG A 82 SITE 2 AC3 11 GLN A 94 SER A 98 GLU A 106 GLY A 107 SITE 3 AC3 11 HIS A 114 HIS A 115 TH2 A 120 CRYST1 43.984 43.984 54.708 90.00 90.00 90.00 P 41 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022736 0.000000 0.000000 0.00000 SCALE2 0.000000 0.022736 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018279 0.00000